Antimicrobial+drug unit 11
Antimicrobial Drugs for BIO2100
Modes of Action of Anti-Bacterial Drugs
Inhibition of Cell-Wall Biosynthesis
Beta lactams:
Penicillins: Effective against a broad range of Gram-positive and some Gram-negative bacteria; disrupts peptidoglycan layer in bacterial cell wall.
Cephalosporins: Have a broader spectrum than penicillins; classified into generations (1st-5th) with varying effectiveness against different bacteria.
Monobactams: Primarily effective against Gram-negative bacteria; Aztreonam is a notable example.
Carbapenems: Broad-spectrum agents effective against a wide array of bacteria, utilized for severe infections; include Imipenem and Meropenem.
Glycopeptides:
Vancomycin: Effective against Gram-positive bacteria, especially MRSA; binds to the D-Ala-D-Ala terminus of peptidoglycan precursors, inhibiting cell wall synthesis.
Bacitracin: Effective for localized skin infections, inhibits the transport of peptidoglycan precursors.
Inhibition of Protein Synthesis (Translation)
Inhibits Prokaryotic Ribosomes:
Tetracycline (e.g., Doxycycline): Binds to the 30S ribosomal subunit, inhibiting tRNA binding; side effects include phototoxicity and discoloration of teeth due to chelation with calcium.
Aminoglycosides:
Gentamicin: Treats serious infections caused by Gram-negative bacteria.
Neomycin: Often used topically, as it is nephrotoxic when used systemically.
Streptomycin: First-line treatment for tuberculosis.
Macrolides:
Erythromycin: Effective against atypical pneumonia and some Gram-positive bacteria; side effects may include gastrointestinal upset.
Chloramphenicol: Broad-spectrum; used in severe infections and for bacterial meningitis; side effect includes aplastic anemia.
Inhibition of Nucleic Acid Synthesis
DNA Synthesis Inhibitors:
Fluoroquinolones (e.g., Ciprofloxacin, Nalidixic Acid): Inhibit bacterial DNA gyrase and topoisomerase IV, leading to DNA strand breakage.
RNA Synthesis Inhibitors:
Rifamycin, Rifampin: Primarily used for tuberculosis; inhibits bacterial RNA polymerase.
Inhibitors of Plasma Membranes
Polymyxin B, Colistin: Effective against Gram-negative bacteria; disrupt membrane integrity. Associated with nephrotoxicity and neurotoxicity.
Daptomycin: Effective against Gram-positive bacteria; disrupts membrane potential; used against MRSA infections.
Inhibitors of Crucial Enzymes or Metabolic Pathways
Sulfonamides (Sulfamethoxazole), Trimethoprim: Combined often as TMP-SMX; inhibits folic acid synthesis, essential for nucleic acid synthesis.
Antimycobacterial Agents:
Izoniazid: Inhibits mycolic acid synthesis, critical for mycobacterial cell walls; side effects include hepatotoxicity and neurotoxicity.
Ethambutol: Inhibits incorporation of mycolic acid into the cell wall.
Antifungal Drugs
Ergosterol Synthesis Inhibitors
Miconazole, Ketoconazole, Fluconazole: Interfere with ergosterol synthesis, essential component of fungal cell membranes; effective against various fungal infections.
Nystatin: Used topically for fungal infections, particularly Candida; nephrotoxic if administered systematically.
Amphotericin B: Broad-spectrum antifungal; binds to ergosterol and causes cell membrane permeability; significant nephrotoxicity is a major concern.
Cell Wall Synthesis Inhibitor
Chitin Inhibitors:
Caspofungin: Inhibits the enzyme involved in chitin synthesis, providing treatment against fungal infections like candidiasis.
Nucleic Acid Synthesis Inhibitor
Flucytosine: Converted to 5-FU; inhibits fungal nucleic acid synthesis.
Spindle Fiber (Mitotic) Inhibitor
Grisofulvin: Inhibits fungal mitosis; used in dermatophyte infections; side effects include hepatotoxicity.
Antiprotozoal Drugs
Interfere with Nucleic Acid Synthesis:
Quinine derivatives (Chloroquine): Antimalarial, inhibits heme polymerase in malaria parasites.
Metronidazole: Effective against Giardia and anaerobic bacteria; disrupts DNA synthesis.
Antihelminthic Drugs
Nicosamide: Inhibits ATP formation in anaerobic environments; effective against tapeworms; has some antibacterial, antiviral, and antitumor effects.
Antiviral Drugs
Nucleoside Analogs:
Acyclovir, Ribavirin: Inhibit nucleic acid biosynthesis, often used in viral infections.
Inhibit Viral Escape:
Neuraminidase inhibitors: Prevents release of virus from infected cells; examples include Tamiflu (Oseltamivir) and Relenza (Zanamivir).
HIV Drugs:
Reverse Transcriptase Inhibitors (AZT - Azidothymidine): Inhibit HIV reverse transcriptase, preventing viral replication.
Protease Inhibitors: Interfere with the protease enzyme required for viral maturation.
Integrase Inhibitors: Inhibit the integration of viral DNA into the host genome.
Fusion Inhibitors and Entry Inhibitors: Block the entry of HIV into host cells, preventing infection.